Clinical trial
Non-inferiority of Angiography-derived Physiology Guidance Versus Usual Care in an All-comers PCI Population Treated With Unrestricted Use of the Healing-Targeted Supreme (HT Supreme) Drug-eluting Stent and P2Y12 Inhibitor Monotherapy After 1-month of Dual-antiplatelet Therapy
NCT04923191 is registered in ClinicalTrials.gov with National University of Ireland, Galway, Ireland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-inferiority of Angiography-derived Physiology Guidance Versus Usual Care in an All-comers PCI Population Treated With Unrestricted Use of the Healing-Targeted Supreme (HT Supreme) Drug-eluting Stent and P2Y12 Inhibitor Monotherapy After 1-month of Dual-antiplatelet Therapy
- Lead sponsor
- National University of Ireland, Galway, Ireland
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 12, 2021
- Completion date
- January 31, 2029
- Enrollment
- 2,540 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.